Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors
Beth Zhou(University of California San Diego), H. Irene Su(University of California San Diego), Brian W. Whitcomb(United States Department of Health and Human Services), Kathryn J. Ruddy(Mayo Clinic in Arizona), Paul C. Nathan(University of Toronto), Henry J. Henk(Rutgers, The State University of New Jersey), James D. Murphy(University of California San Diego), Brian Kwan(University of San Diego), Milli J. Desai(University of California San Diego), Vinit Nalawade(University of California San Diego)
Cited by 20
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Youden Index and Optimal Cut‐Point Estimated from Observations Affected by a Lower Limit of Detection
|Biometrical Journal|2008|1.3k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589
Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
|New England Journal of Medicine|2016|576